| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 08/05/2009 | EP1509506B1 Pyridazine derivatives |
| 08/05/2009 | EP1503778B1 Formulation of a mixture of free-b-ring flavonoids and flavans as a therapeutic agent |
| 08/05/2009 | EP1501797B1 3-(substituted amino)-1h-indole-2-carboxylic acid ester and 3-(substituted amino)-benzo[b]thiophene-2-carboxylic acid ester derivatives as interleukin-4 gene expression inhibitors |
| 08/05/2009 | EP1401825B1 Thiophene derivatives as antiviral agents for flavivirus infection |
| 08/05/2009 | EP1286703B1 Methods and compounds for controlled release of recombinant parvovirus vectors |
| 08/05/2009 | EP1253939B1 In vivo ctl elicitation by heat shock protein fusion proteins maps to a discrete atp binding domain and is cd4+ t cell-independent |
| 08/05/2009 | EP1246913B1 Molecular clones with mutated hiv gag/pol, siv gag and siv env genes |
| 08/05/2009 | EP1029054B1 Hp90: host membrane receptor for pathogenic bacteria, encoded by the bacterial tir gene |
| 08/05/2009 | CN101501064A Glycopeptide antibiotic derivative |
| 08/05/2009 | CN101501063A Polymyxin derivatives and uses thereof |
| 08/05/2009 | CN101501061A Macrocyclic compounds as antiviral agents |
| 08/05/2009 | CN101501051A Amides as sphingomyeline inhibitors |
| 08/05/2009 | CN101501038A Fused [d]pyridazin-7-ones |
| 08/05/2009 | CN101501015A Use of coumarin derivatives in antifungal therapy |
| 08/05/2009 | CN101501002A Non-nucleoside reverse transcriptase inhibitors |
| 08/05/2009 | CN101500604A Plasmids with immunological action |
| 08/05/2009 | CN101500587A Antiviral product |
| 08/05/2009 | CN101500584A Use of micron sulfur in prevention and treatment for pathogenic disorder of human or animal |
| 08/05/2009 | CN101500552A Antiviral use of cationic surfactant |
| 08/05/2009 | CN101500534A Compositions comprising betulonic acid |
| 08/05/2009 | CN101497882A Anti- mycobacterium tuberculosis infection small molecule nucleotide DNA aptamer and preparation thereof |
| 08/05/2009 | CN101497877A Influenza all-virus attenuated live vaccine recombinant, construction method and use thereof |
| 08/05/2009 | CN101497661A Heaven dragon polypeptide derivative, as well as preparation and application thereof |
| 08/05/2009 | CN101497641A Method for synthesizing delta 24(28) cholesterol compounds |
| 08/05/2009 | CN101497621A 1,5-dihydro-2H-pyrrol-2-one tricyclic derivatives having anti-infective activity |
| 08/05/2009 | CN101497620A Purification method of penicillin and cephalosporin |
| 08/05/2009 | CN101497612A Novel carbostyrile compound, preparation and use |
| 08/05/2009 | CN101497580A HIV-1 inhibitor 2-pyrrolidinone derivative, as well as synthesizing method and use thereof |
| 08/05/2009 | CN101497557A Method for extracting purified solanesol from potato leaf |
| 08/05/2009 | CN101496929A Nose-protecting device for killing bacteria and virus |
| 08/05/2009 | CN101496900A Immunity enhancement adjuvant of novel vaccine |
| 08/05/2009 | CN101496898A Vaccine for preventing and/or treating Helicobacter pylori infection |
| 08/05/2009 | CN101496897A Vaccine for fish and application |
| 08/05/2009 | CN101496845A Hedyotis diffusa Willd. extract and method for separating and preparing the same |
| 08/05/2009 | CN101496820A Active extract of facultative anaerobic sea Pseudomonas stuszeri as well as production method and use thereof |
| 08/05/2009 | CN101496811A Soluble and stable tilmicosin composition |
| 08/05/2009 | CN101496810A Soluble and stable composition of tilmicosin and sulfonamides |
| 08/05/2009 | CN101496791A Cefixime sustained-release tablets and preparation method thereof |
| 08/05/2009 | CN101496773A Antimicrobial lotion containing wood frog antimicrobial peptide and preparation method thereof |
| 08/05/2009 | CN101496591A Effervescent tablet containing ginger component |
| 08/05/2009 | CN101496555A Lactobacillus micro-capsule as well as preparation method and use |
| 08/05/2009 | CN100523215C RNA interference mediating small RNA molecules |
| 08/05/2009 | CN100523192C Vaccines from infectious agents |
| 08/05/2009 | CN100523187C Modified chimeric polyeptides with improved pharmacokinetic properties |
| 08/05/2009 | CN100523177C Pig replication and respiration syndrome virus attenuated vaccine strain and uses thereof |
| 08/05/2009 | CN100522995C Cell wall acyl-alanyl-D-isoglutamine derivative and its preparation, medicine composition and use |
| 08/05/2009 | CN100522993C Odorranagrahami antimicrobialpeptides and application thereof |
| 08/05/2009 | CN100522991C Peptidomimetic protease inhibitors |
| 08/05/2009 | CN100522967C Phosphorus-containing compounds & uses thereof |
| 08/05/2009 | CN100522955C Cytotoxic agents containing novel potent taxanes and their therapeutic use |
| 08/05/2009 | CN100522249C Elogated and multiple spacers in activatible prodrugs |
| 08/05/2009 | CN100522229C Health-care potables and its preparing method |
| 08/05/2009 | CN100522189C Method for preparing broad-spectrum antiviral drug of nano total acid of chickweed as well as usage and chickweed acid A |
| 08/05/2009 | CN100522180C Anti-infection nano montmorillonite and its preparation method |
| 08/05/2009 | CN100522176C Medicine composition for treating vaginal diseases |
| 08/05/2009 | CN100522175C Sustained release tablet of oleanolic acid and its preparation method |
| 08/05/2009 | CN100522172C Non-sedating barbiturate compounds as neuroprotective agents |
| 08/05/2009 | CN100522160C Application of indole-2, 3-diketone in preparing antimycotics medicament |
| 08/05/2009 | CN100522154C Use of isothiocyanates compound for treatment of helicobacter |
| 08/05/2009 | CN100521957C Supine gynura root and producing method thereof |
| 08/04/2009 | US7569724 Antiproliferative agnets; anticancer agents; skin disorders |
| 08/04/2009 | US7569697 Benzimidazole compound crystal |
| 08/04/2009 | US7569683 Nucleotide sequences coding bacterial cell surface proteins for use in generating monoclonal antibodies for prevention and treatment of infection |
| 08/04/2009 | US7569678 Protease inhibitor conjugates and antibodies useful in immunoassay |
| 08/04/2009 | US7569663 Genetically engineered fusion proteins for use in diagnosis and treatment of cancer, viral infections, autoimmune and alloimmune diseases |
| 08/04/2009 | US7569591 topoisomerase inhibitors such as [5-(4-Cyclopropylcarbamoyl-imidazol-1-yl)-7-pyrimidin-2-yl-1H-benzoimidazol-2-yl]-carbamic acid ethyl ester, used for prophylaxis of bacterial infections in mammals |
| 08/04/2009 | US7569587 Such as 14-O[(N-(3-Methyl-2-amino-buturyl-piperidin-3(S)-yl)sulfanyl)acetyl]mutilin |
| 08/04/2009 | US7569575 Synthesis of locked nucleic acid derivatives |
| 08/04/2009 | US7569573 Nucleobase substituted with a 2-hydroxy-4-oxobut-2-enoic acid or ester or a 1-hydroxy-3-oxopropenephosphonic acid or ester, e.g., Methyl 4-(1,3-dibenzyl-1,2,3,4-tetrahydro-2,4-dioxopyrimidin-5-yl)-2-hydroxy-4-oxobut-2-enoate |
| 08/04/2009 | US7569549 Crystallizing in water-miscible solvent, water, and mineral/organic acid |
| 08/04/2009 | US7569387 Specifically binds an MK61 polypeptide produced by immunizing an animal |
| 08/04/2009 | US7569383 Chimeric flavivirus vectors |
| 08/04/2009 | CA2566440C An antimycobacterial pharmaceutical composition |
| 08/04/2009 | CA2424566C Dental care compositions |
| 08/04/2009 | CA2420348C Non-hormonal vaginal contraceptive |
| 08/04/2009 | CA2365281C Human antibodies that bind human il-12 and methods for producing |
| 08/04/2009 | CA2207850C Use of mono and bicarboxylic acid amides for the manufacture of a medicament active at the peripheral cannabinoid receptor |
| 08/04/2009 | CA2194673C A conjugate between a modified superantigen and a target-seeking compound and the use of the conjugate |
| 07/30/2009 | WO2009094191A2 Methods of treating viral infections |
| 07/30/2009 | WO2009094190A2 Methods of treating viral infections |
| 07/30/2009 | WO2009094157A1 Dihydro- 1h- pyrrolo [1,2-a] indol-1-yl carboxylic derivatives which act as s1p1 agonists |
| 07/30/2009 | WO2009093638A1 PROCESS FOR PRODUCTION OF β-LACTAM COMPOUND |
| 07/30/2009 | WO2009093540A1 Chlorine dioxide liquid preparation composition |
| 07/30/2009 | WO2009092897A1 Compounds for preventing or treating a viral infection |
| 07/30/2009 | WO2009092810A2 Single pharmaceutical composition containing antibiotics and probiotics |
| 07/30/2009 | WO2009092787A1 Lactylates for the prevention and treatment of infections caused by gram-positive bacteria in animals |
| 07/30/2009 | WO2009092716A1 Crystalline form of abacavir that is essentially free of solvent |
| 07/30/2009 | WO2009092612A1 Hydrophobic modified pres-derived peptides of hepatitis b virus (hbv) and their use as vehicles for the specific delivery of compounds to the liver |
| 07/30/2009 | WO2009092295A1 A set of geldanamycin derivatives and their preparation methods |
| 07/30/2009 | WO2009092293A1 Pyrollidine-based compounds |
| 07/30/2009 | WO2009092284A1 Benzocycloheptene derivatives, preparing processes and pharmaceutical uses thereof |
| 07/30/2009 | WO2009056322A3 Foam stabilizer for a sterilization composition |
| 07/30/2009 | WO2009043464A3 Astressin and beta- endorphin for use as therapeutic agents |
| 07/30/2009 | WO2009043451A3 Use of chorionic gonadotropin-beta (109-145) as a therapeutic agent |
| 07/30/2009 | WO2009043450A3 Use of neurotrophic factor for retinal cholinergic neurons (nfrcn) and chorionic gonadotropin-beta (109-145) as therapeutic agents |
| 07/30/2009 | WO2009043449A3 Use of a peptide as a therapeutic agent |
| 07/30/2009 | WO2009043447A3 Use of a peptide as a therapeutic agent |
| 07/30/2009 | WO2009040004A3 Use of a peptide as a therapeutic agent |
| 07/30/2009 | WO2009037503A3 New combination - 012 for the treatment of respiratory diseases |
| 07/30/2009 | WO2009034346A3 Anti-bacterial agents |